Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC.
European Neuropsychopharmacology December 2017 Tomáš Hložek, Libor Uttl, Lukáš Kadeřábek et al.
Metabolic and behavioural effects of, and interactions between Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are influenced by dose and administration route. Therefore we investigated, in Wistar rats, effects of pulmonary, oral and subcutaneous (sc.) THC, CBD and THC+CBD. Concentrations of THC, its metabolites 11-OH-THC and THC-COOH, and CBD in serum and brain were determined over 24h,...
DOI: 10.1016/j.euroneuro.2017.10.037 (opens in new tab)
Full text (opens in new tab)
Behaviour
Cannabidiol CBD
Pharmacokinetics
δ9-Tetrahydrocannabinol THC